# US 2025/0367206 A1 · 1-methylxanthine-based bioactive composition and method of use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0367206 A1
- Document ID: US20250367206A1
- Status: Published application
- Kind: A1
- Application number: 19/303,219
- Filed: 2025-08-18
- Published: 2025-12-04
- Earliest claimed: 2021-04-07
- Assignees: Ingenious Ingredients, LP
- Applicants: Ingenious ingredients, LP
- Inventors: Martin Purpura; Ralf Jäger; Shawn Wells; Kylin Liao
- Web page: https://patentgrep.com/patent/US20250367206A1

## CPC

- A61K 31/522: having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The disclosed compositions, systems and methods relate to a dietary supplement for human consumption and comprises 1-methylxanthine and optionally other compounds that modulate the effects of 1-methylxanthine. Uses for the 1-methylxanthine-containing supplements contain improvement of at least one of endurance performance, mood, vigor, lipolysis, energy expenditure, exercise performance, and/or decreased appetite.

## Claims

### Claim 1

A composition for increasing energy in a subject comprising 1-methylxanthine and paraxanthine.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the paraxanthine and 1-methylxanthine are each present in an amount from about 2 mg to about 800 mg.

### Claim 3 (depends on 2)

The composition of claim 2, wherein the paraxanthine and 1-methylxanthine are each present in an amount from about amount from 50 mg to about 400 mg.

### Claim 4 (depends on 1)

The composition of claim 1, further comprising an active agent, selected from a group consisting of: L-theanine, phosphatidylcholine, alpha-GPC (L-alpha glycerylphosphorylcholine), Citicoline (Cytidine diphosphate choline (CPD Choline)), Choline Bitartrate, Bacopa Monnieri, Phosphatidylserine, pilocarpine, and cevimeline Amburana cearensis, Lippia sidoides, Paullinia cupana, Plathymiscium floribundum, tetrahydrocurcumin, and Solanum asperum and/or combinations thereof, gallic acid, (+)-catechin (C), (−)-epicatechin (EC), (+)-gallocatechin (GC), (−)-epigallocatechin (EGC), (−)-catechin gallate (CG), (−)-gallocatechin gallate (GCG), (−)-epicatechin gallate (ECG) and (−)-epigallocatechin gallate (EGCG), glycerides, propylene glycol, lauroyl macrogol, lauroyl macrogol derivatives, co-crystallization products of bioperine, piperine, black pepper, bergamottin, dihydroxybergamottin (CYP3A4), flavonoids (naringin, hesperidin, nobiletin, tangeretin, quercetin), pterostilbene, fisetin, phytosomes, salicin, fish oil (omega-3 fatty acids and specialized, small lipid pro-resolving epoxide derivatives), oxylipins, tart cherry, krill oil, astaxanthin, proteolytic enzymes, glucosamine sulfate, chondroitin sulfate, MSM (methylsulfonylmethane), SAMe (S-adenosylmethionine), ASU (avocado-soybean unsapponifiable fraction), cetyl myristoleate, Dolichos falcate, triterpenoids, acacia catechu, Andrographis paniculata, Scutalleria baicalensis, Agmatine sulfate, Stinging Nettle, Sea Buckthorn, Curcumin, Cissus Quadrilangularis, Boswellia Serrata, Wasabia japonica (wasabi extract for Tea Tree Oil), Emu Oil, Arnica, Mangifera indica L. (Anacardiaceae), Lagenaria breviflora, Zingiber officinale (ginger & gingerols/shogaols), hoodia gordonii, caffeine, yohimbine, methylsynephrine, synephrine, theobromine, tocopherols, theophylline, alpha-yohimbine, conjugated linoleic acid (CLA), octopamine, evodiamine, passion flower, red pepper, cayenne, raspberry ketone, guggul, green tea, guarana, kola nut, beta-Phenethylamines, Acacia rigidula, forskolin (Coleus forskohlli), theophylline, synephrine, yohimbine, rhodiola, ashwagandha, ginseng, ginkgo biloba, siberian ginseng, astragalus, licorice, green tea, reishi, dehydroepiandrosterone (DHEA), pregnenolone, tyrosine, N-acetyl-tyrosine, glucuronolactone, taurine, Acetyl-L-carnitine, 5-hydroxytryptophan, tryptophan, Phenethylamines, Sceletium tortuosum (and Mesembrine alkaloids), Dendrobium sp., Acacia rigidula, PQQ (Pyroloquinoline quinone), Ubiquinone(01), Nicotinamide riboside, picamilon, Huperzine A (Chinese clubmoss or Huperzia serrata, L-dopa, Mucuna pruriens, forskolin (Coleus forskohlli), 2-(dimethylamino)ethanol (DMAE), DMAE bitartrate, medium chain triglycerides, creatine, citrulline, arginine, lions mane, cordyceps, leucine, isoleucine, valine, BAIBA, ergothioneine, grains of paradise, Kanna, Huperzine A, ketones, Maca, ginseng, ashwagandha, rhodiola, theanine BCAAs, beta-alanine, fish oil, citrulline, arginine, hydroxy-methylbuterate, HICA, balenine, carnosine, anserine and combinations thereof.

### Claim 5 (depends on 1)

The composition of claim 1, wherein administration of the composition to a subject produces a synergistic increase in energy relative to the administration of a comparable dose of paraxanthine or 1-methylxanthine alone.

### Claim 6 (depends on 1)

The composition of claim 1, wherein 1-methylxanthine and paraxanthine are present at a ratio of about 4:1 to about 1:4.

### Claim 7

A method for increasing energy in a subject comprising administering to the subject a composition comprising an effective amount of 1-methylxanthine.

### Claim 8 (depends on 7)

The method of claim 7, wherein the amount of 1-methylxanthine administered is from about 2 mg to about 800 mg.

### Claim 9 (depends on 7)

The method of claim 7, wherein the subject experiences and increase in perception of energy of at least about 5%.

### Claim 10 (depends on 7)

The method of claim 7, wherein the subject experiences a decrease of at least one of anxiety, fatigue, perception of effort, and/or perception of pain.

### Claim 11 (depends on 7)

The method of claim 7, wherein the composition further comprises paraxanthine in an amount from about 2 mg to about 800 mg.

### Claim 12 (depends on 11)

The method of claim 11, wherein the administration of paraxanthine and 1-methylxanthine produce a synergistic increase in perception of energy in the subject, relative to the administration of a comparable dose of paraxanthine or 1-methylxanthine alone.

### Claim 13 (depends on 7)

The method of claim 7, wherein the composition further comprises at least one ingredient selected from the group consisting of L-theanine, phosphatidylcholine, alpha-GPC (L-alpha glycerylphosphorylcholine), Citicoline (Cytidine diphosphate choline (CPD Choline)), Choline Bitartrate, Bacopa Monnieri, Phosphatidylserine, pilocarpine, and cevimeline Amburana cearensis, Lippia sidoides, Paullinia cupana, Plathymiscium floribundum, tetrahydrocurcumin, and Solanum asperum and/or combinations thereof, caffeine, theobromine, naringin, hesperidin, 2-(dimethylamino) ethanol (DMAE), DMAE bitartrate, magnolia bark, theanine, phosphatidylserine, ashwagandha, rhodiola, taurine, tyrosine, n-acetyl-tyrsoine, macuna, Sceletium tortuosa, 5-HTP, tryptophan, saffron, Vitamin D, SAMe, lions mane and huperzine A.

### Claim 14 (depends on 7)

The method of claim 7, wherein the composition is substantially free of caffeine.

### Claim 15

A method for improving athletic performance in a subject in comprising administering to the subject a composition comprising an effective amount of 1-methylxanthine.

### Claim 16 (depends on 14)

The method of claim 14, wherein the amount of 1-methylxanthine administered is from about 50 mg to about 400 mg.

### Claim 17 (depends on 15)

The method of claim 15, wherein athletic performance is increased by at least about 10%.

### Claim 18 (depends on 15)

The method of claim 15, wherein the subject experiences and increase in endurance.

### Claim 19 (depends on 15)

The method of claim 15, wherein the composition further comprises paraxanthine in an amount from about 2 mg to about 800 mg and wherein administration of the composition to a subject produces a synergistic increase in athletic performance to the administration of a comparable dose of paraxanthine or 1-methylxanthine alone.

### Claim 20 (depends on 15)

The method of claim 15, wherein the composition further comprises at least one agent selected from the group consisting of L-theanine, phosphatidylcholine, alpha-GPC (L-alpha glycerylphosphorylcholine), Citicoline (Cytidine diphosphate choline (CPD Choline)), Choline Bitartrate, Bacopa Monnieri, Phosphatidylserine, pilocarpine, and cevimeline Amburana cearensis, Lippia sidoides, Paullinia cupana, Plathymiscium floribundum, tetrahydrocurcumin, and Solanum asperum and/or combinations thereof, caffeine, theobromine, naringin, hesperidin, 2-(dimethylamino) ethanol (DMAE), DMAE bitartrate, huperzine A, theacrine, methylliberine, B12, sulbutiamine, magnolia bark, ketones, MCTs, omega 3's, lutein, zeaxanthin, tyrosine and n-acetyl-tyrosine, taurine, acetyl-l-carnitine and/or combinations thereof.
